Search results
Results from the WOW.Com Content Network
Oxycodone is also widely available across Western Canada, but methamphetamine and heroin are more serious problems in larger cities, while oxycodone is more common in rural towns. Oxycodone is diverted through doctor shopping , prescription forgery, pharmacy theft, and overprescription.
OxyContin is a trade name for the narcotic oxycodone hydrochloride, a painkiller available by prescription only. This and the general “lack of transparency” is just one of the many complaints ...
Oxycodone, marketed under the brand name Oxycontin, played a significant role in fueling the opioid epidemic in the United States. [19] Purdue Pharma ’s aggressive marketing tactics, including physician targeting and misleading advertising, contributed to the widespread overuse and overprescription of the drug. [ 20 ]
According to the Drug Enforcement Administration (DEA), in 2010 a single CVS pharmacy in Sanford ordered 1.8 million oxycodone pills, an average of 137,994 pills a month. Other pharmacy customers in Florida averaged 5,364 oxycodone pills a month. DEA investigators serving a warrant to a CVS pharmacy in Sanford on October 18, 2011 noted that ...
Members of the Sackler family who own OxyContin maker Purdue Pharma have been cast as prime villains in the U.S. opioid epidemic. The Supreme Court on Thursday rejected a deal for the company to ...
Opioids are a diverse class of moderate to strong painkillers, including oxycodone (commonly sold under the trade names OxyContin and Percocet), hydrocodone (Vicodin, Norco), and fentanyl (Abstral, Actiq, Duragesic, Fentora), which is a very strong painkiller that is synthesized to resemble other opiates such as opium-derived morphine and ...
This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources. The timeline of the opioid epidemic includes selected events related to the origins of Stamford, Connecticut-based Purdue Pharma, the Sackler family, the development and marketing of oxycodone, selected FDA activities related to the abuse ...
As of 2012, the most recent year for which federal data were available, just 13 states had enough doctors certified to prescribe buprenorphine to their addicted residents, according to a study published in August in the American Journal of Public Health.